The medtech industry is facing a more complex regulatory landscape than ever before. With EU MDR maintenance and IVDR preparation alongside growing pressures from competition and rising costs of manufacturing, many are exploring new ways to improve their bottom lines.
To ensure ongoing compliance, patient safety, business longevity, and competitive advantage, medtech companies should embrace digital transformation, which allows organizations to support cross-functional data efficiency, increase 24/7 insights, reduce compliance challenges, and speed time to market. However, the selection and adoption of digital technologies require focus and thorough analysis.
In this webinar, we highlight:
Medical Affairs is evolving and enabling fast, compliant, strategic engagement with HCPs and KOLs. Connectivity across channels is imperative to get products to patients and to understand their needs.
Join this webinar for insights on:
Ascensia Diabetes Care, Global Program Lead, Ntianu Onumonu will share how the company implemented a claims and content management program that reduces review and approval times, enhances compliance, and streamlines marketing operations.
Ntianu will share:
João Martins, Associate Director of Regulatory Affairs Strategy at Abbott, and Megha Deviprasad Iyer, Director of Global Strategic Regulatory Affairs at Thermo Fisher Scientific will address the growing challenges for regulatory affairs professionals amid increasing global health regulations and shifting priorities.
They will discuss: